Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 3/20 | 0.64 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.64 |
| ▸ | ITGAL | P20701 | 3/20 | 0.64 |
| ▸ | CA1 | P00915 | 3/20 | 0.57 |
| ▸ | CA2 | P00918 | 3/20 | 0.57 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | REN | P00797 | 1/20 | 0.53 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.52 |
| ▸ | QPCT | Q16769 | 1/20 | 0.51 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.49 |
| ▸ | GGT1 | P19440 | 1/20 | 0.49 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15683044 | 1.00 | ITGB2 (0.64) | ITGB2ICAM1ITGALCA1CA2 | |
| SCHEMBL6026427 | 1.00 | ITGB2 (0.64) | ITGB2ICAM1ITGALCA1CA2 | |
| Water SCHEMBL8680774 | 0.98 | ITGB2 (0.63) | ITGB2ICAM1ITGALCA1CA2 | |
| SCHEMBL15080457 | 0.89 | REN (0.54) | ITGB2ICAM1ITGALCA1CA2 | |
| SCHEMBL9860623 | 0.89 | ITGB2 (0.57) | ITGB2ICAM1ITGALCA1CA2 | |
| SCHEMBL27413426 | 0.88 | ITGB2 (0.67) | ITGB2ICAM1ITGALCA1CA2 | |
| SCHEMBL18676311 | 0.86 | SLC6A5 (0.59) | ITGB2ICAM1ITGALCA1CA2 | |
| SCHEMBL21048720 | 0.86 | ITGB2 (0.59) | ITGB2ICAM1ITGALCA1CA2 | |
| SCHEMBL6806998 | 0.85 | ITGB2 (0.62) | ITGB2ICAM1ITGALCA1CA2 | |
| SCHEMBL5808674 | 0.85 | HTR1D (0.51) | ITGB2ICAM1ITGALCYP3A4SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 839 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | claimed |
| US-20260026495-A1 | STABLE PLASMIN COMPOSITIONS FOR ORGAN PRESERVATION AND RECONDITIONING | GRIFOLS WORLDWIDE OPERATIONS LTD (IE) | 2026-01-29 | — | — | US | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| EP-3615069-B1 | N-ACETYLATED AND NON-ACETYLATED DIPEPTIDES CONTAINING ARGININE TO REDUCE THE VISCOSITY OF VISCOUS COMPOSITIONS OF THERAPEUTIC POLYPEPTIDES | AMGEN INC (US) | 2025-05-28 | — | — | EP | claimed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | claimed |
| CN-119584859-A | Stable plasmin compositions for organ preservation and conditioning | 基立福环球运营有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-114269951-B | Diagnostic method for aesthetic deterioration of skin | 欧莱雅 | 2024-12-27 | — | — | CN | claimed |
| CN-118406439-B | Chemical mechanical polishing composition and application thereof in tungsten chemical mechanical polishing | 万华化学集团电子材料有限公司 | 2024-10-18 | — | — | CN | claimed |
| EP-1344515-A1 | SKIN COSMETICS | Shu Uemura Cosmetics Inc. (JP) | 2003-09-17 | — | — | EP | claimed |
| US-6524593-B1 | Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails | TRISTRATA, INC. | 2003-02-25 | — | — | US | claimed |
| US-6159485-A | COSMETICS; SKIN DISORDERS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-12-12 | — | — | US | claimed |
| WO-2000040217-B1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-10-05 | — | — | WO | claimed |
| US-5925317-A | Dual neutralization system for iodine treatment of contact lenses | BAUSCH & LOMB INCORPORATED (US) | 1999-07-20 | — | — | US | claimed |
| EP-0885019-A1 | DUAL NEUTRALIZATION SYSTEM FOR IODINE TREATMENT OF CONTACT LENSES | BAUSCH & LOMB INCORPORATED (US) | 1998-12-23 | — | — | EP | claimed |
| EP-0433112-B1 | Modified gangliosides and the functional derivatives thereof | FIDIA SPA (IT) | 1998-10-28 | — | — | EP | claimed |
| WO-1997026923-A1 | DUAL NEUTRALIZATION SYSTEM FOR IODINE TREATMENT OF CONTACT LENSES | BAUSCH & LOMB INCORPORATED (US) | 1997-07-31 | — | — | WO | claimed |
| WO-1993002689-A1 | SYNTHETIC RIBONUCLEASES AND METHODS FOR PREPARING AND USING SAME | UNIVERSITY OF MEDICINE & DENTISTRY (US) | 1993-02-18 | — | — | WO | claimed |
| EP-0433112-A1 | Modified gangliosides and the functional derivatives thereof | FIDIA S.p.A. (IT) | 1991-06-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260026495-A1 | STABLE PLASMIN COMPOSITIONS FOR ORGAN PRESERVATION AND RECONDITIONING | PLG, PLPBP, F2 | ITGB2 2426/4885ICAM1 3676/4885ITGAL 2293/4885 |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | IAPP, GPR119, FAHD1 | ITGB2 2550/4885ICAM1 1885/4885ITGAL 3474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.